Daniel Morris
Hematology & Oncology · Naples, FLNPI 1265595060
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 201 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 12.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $3,161 and has fallen 99.4% since, to $19 in 2022. That places this record below the midpoint for hematology & oncology clinicians in FL, where the typical reported total is $3,884.
Across 201 payments — averaging $18.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$445
- Merck$371
- Amgen$352
- Genentech USA, Inc.$283
- Bristol Myers Squibb$234
- Lilly USA, LLC$175
- plus $2K from 27 others
What the payments were for
- Food & beverage$3,669100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 20 | $445 |
| Merck | 22 | $371 |
| Amgen | 15 | $352 |
| Genentech USA, Inc. | 13 | $283 |
| Bristol Myers Squibb | 12 | $234 |
| Lilly USA, LLC | 9 | $175 |
| Astellas Pharma US Inc | 11 | $175 |
| Sanofi | 10 | $174 |
| Johnson & Johnson(2 entities) | 15 | $171 |
| E.r. Squibb & Sons, L.L.C. | 10 | $163 |
| AstraZeneca | 5 | $157 |
| Pfizer | 11 | $154 |
| Seagen Inc. | 7 | $111 |
| Foundation Medicine, Inc. | 2 | $88 |
| Clovis Oncology, Inc. | 5 | $73 |
| Aurobindo Pharma USA, Inc. | 4 | $55 |
| Eisai Inc. | 2 | $51 |
| Heron Therapeutics, Inc. | 2 | $47 |
| Rigel Pharmaceuticals, Inc. | 3 | $47 |
| AbbVie | 3 | $45 |
| Puma Biotechnology, Inc. | 3 | $42 |
| Bayer | 2 | $39 |
| Partner Therapeutics, Inc. | 2 | $39 |
| EMD Serono, Inc. | 2 | $33 |
| Dendreon Pharmaceuticals LLC | 1 | $31 |
| Incyte Corporation | 1 | $22 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| Karyopharm Therapeutics Inc. | 1 | $16 |
| Array Biopharma Inc | 1 | $16 |
| Exelixis Inc. | 1 | $15 |
| Agios Pharmaceuticals, Inc. | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
| Veracyte, Inc. | 3 | $2 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Nplate$118
How this compares
$3,669 in reported general payments places this provider in the 45th percentile of 694 hematology & oncology providers in Florida.
Other hematology & oncology in Naples
- Martin DietrichRockledge$6.2M
- Mark SocinskiOrlando$2.4M
- Tarek MekhailOrlando$2.2M
- Edgardo SantosFort Lauderdale$2M
- Daniel LandauOrlando$1.8M
- Wassim McHaylehAltamonte Springs$1.5M
- Edith PerezJacksonville$1.1M
- Steven FeinMiami$1M
- Vamsidhar VelchetiJacksonville$966K
- Shahram MoriOrlando$952K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.